- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02838576
Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women
Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women: a Randomized, Double-blind Controlled Trial
연구 개요
상세 설명
연구 유형
등록 (예상)
단계
- 2 단계
연락처 및 위치
연구 장소
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, 브라질
- 모병
- Comitê de Ética em Pesquisa do Hospital de Clínicas de Porto Alegre
-
연락하다:
- Maria Celeste Osório Wender, Ph.D
- 전화번호: +55513359-8117
- 이메일: mceleste@ufrgs.br
-
연락하다:
- Fernanda Vargas Ferreira, Ph.D
- 전화번호: +55513359-8117
- 이메일: fernandaferreira@unipampa.edu.br
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- age between 45 and 55 years
- chronic arthralgia related to climacteric
- regular mammography and pap smear test in the last twelve months
- availability to attend hormone replacement therapy
- maximum of ten years of amenorrhea according to the criteria of Stages of Reproductive Aging Workshop (STRAW)
- without use of hormone replacement therapy, at least, previous six months
- no contraindication to hormone replacement therapy (current or past of breast and / or cervical cancer, severe current or recent heart disease, thromboembolism, hypertension with no control, metabolic diseases (but stable thyroid disease) and endometrial hyperplasia to be enlightened
- Informed consent
Exclusion Criteria:
- autoimmune diseases
- visceral pain (chronic pelvic pain, dyspareunia, irritable bowel syndrome)
- systemic diseases (rheumatic, neurological, oncology, sexually transmitted infection)
- body mass index of 30 or greater
- soy diet
- abuse of alcohol and drugs
- large surgeries
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Conjugated Equine Estrogen
Thirty-six healthy postmenopausal women aged between 45 and 55 years will receive 0,625 mg/day conjugated equine estrogen (CEE) for 12 weeks. These 1 active pill containing conjugated equine estrogen, 0,625 mg will be provided by a laboratory with no trademark identification. The bottles will be numbered in code by a pharmaceutist not involved directly in study and they will donated to volunteers. During the intervening period, use of conjugated equine estrogen, there will be blinding. After this phase, blinding will be interrupted in order to identify volunteers who used the active drug. |
Use of conjugated equine estrogen for 12 weeks.
Adherence will be monitored during periodical hospital visits in order to receive pills.
다른 이름들:
|
위약 비교기: Placebo
Thirty-six healthy postmenopausal women aged between 45 and 55 years will receive placebo pills, identical in size, shape and color to the active drug, via oral administration, for 12 weeks. The bottles, without trademark identification, will be numbered in code by a pharmaceutist not involved directly in study and they will donated to volunteers. During the intervening period, use of placebo, there will be blinding. After this phase, blinding will be interrupted in order to identify volunteers who used the active drug and placebo. |
Use of placebo for 12 weeks.
Adherence will be monitored during periodical hospital visits in order to receive pills.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Arthralgia
기간: 6 months
|
Arthralgia´ll be measured by numeric scale (0-10).
|
6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Climacteric symptoms
기간: 6 months
|
Climacteric symptoms´ll be evaluated by Menopause Rating Scale - Brazilian Version.
The score increases point by point with increasing severity of subjectively perceived symptoms in each of the 11 items.
|
6 months
|
Level of physical activity
기간: 6 months
|
Level of physical activity´ll be evaluated by International Physical Activity Questionnaire - Brazilian Version whose three levels of physical activity are low, moderate and high.
|
6 months
|
Pain Catastrophizing
기간: 6 months
|
Pain Catastrophizing´ll be evaluated by Pain Catastrophizing - Brazilian Version into three subscales being magnification, rumination, and helplessness.
The higher the score, the more catastrophizing thoughts are present.
|
6 months
|
Health-related quality of life
기간: 6 months
|
Quality of life´ll be evaluated by Women´s Health Questionnaire - Brazilian Version (somatic symptoms, depressed mood, cognitive difficulties, anxiety and fear, sexual functioning, vasomotor symptoms, sleep problems, menstrual problems, and self-perceived attraction).
The higher the score, the more pronounced the suffering and dysfunction.
|
6 months
|
Depression
기간: 6 months
|
Depression´ll be evaluated by Beck Depression Inventory - Brazilian Version.
The standard cut-off scores are minimal, mild, moderate and severe depression.
|
6 months
|
Anxiety
기간: 6 months
|
Anxiety´ll be evaluated by Beck Anxiety Inventory - Brazilian Version.
The standard cut-off scores are minimal, mild, moderate and severe depression.
|
6 months
|
Quality of sleep
기간: 6 months
|
Quality of sleep´ll be evaluated by Pittsburgh Sleep Quality Index - Brazilian Version.
Lower scores denote a healthier sleep quality.
|
6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Maria Celeste Osório Wender, Ph.D, Hospital de Clínicas de Porto Alegre
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 16-0235
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Conjugated Equine Estrogen에 대한 임상 시험
-
Emergent BioSolutionsDepartment of Health and Human Services완전한